Igor Hall

Bachelor of Medicine and Bachelor of Science,  Cleveland Clinic 

Location: India

Consulting Services

Grant Submission Research Consulting Sales and Marketing

Areas Of Interest

Consciousness Social Capital Rock Cresses Swainsonine, (8 alpha)-Isomer Erythroblasts Bronchowern Proton Ionophores Protein Glycosylation Acids, Hexanedioic Phosphatidylinositide 4,5 Bisphosphate Phospholipase C LIPUS CDP Diglyceride Inositol Transferase Ventricular Tumor, Brain KW4943A County Government abl Proto Oncogene Products AMAC 1 Protein Disinhibition Dementia Parkinsonism Amytrophy Complex Sudden Unexplained Death Syndrome Receptor 2, Orexin Mahogany, Mountain Lichenoid Eruptions autumnales, Colchicum Peritoneal Neoplasms Cycloparaffins Jodid Verla Drug Administration, Buccal Treatment, Selection for Receptor, Interleukin-18 Capsule, Plant Technics, Dilution Bean, Kidney Nonsuppressible Insulin Like Activity Aleve Non Medical Internship Acetate, Leuprolide Merkel's Receptor Emergency Responder COUP TFII Protein Digitalis Glycosides

Professional Narrative

Dr. Igor Hall was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Hall has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.

Employment

Executive Director, Amgen 1994
Executive Director, Harvard Med 2012

Education

Bachelor of science in nursing, Yale School of Medicine 2014
Director Medicine, Weill Medical College 1992

Referees

Publications

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.

Platt RJ, Chen S, Zhou Y, Yim MJ, Swiech L, Kempton HR, Dahlman JE, Parnas O, Eisenhaure TM, Jovanovic M, Graham DB, Jhunjhunwala S, Heidenreich M, Xavier RJ, Langer R, Anderson DG, Hacohen N, Regev A, Feng G, Sharp PA, Zhang F. CRISPR- Cas9 knockin mice for genome editing and cancer modeling. Cell. 2014 Oct 9;159(2):440-55. doi: 10.1016/j.cell.2014.09.014. Epub 2014 Sep 25. PMID: 25263330; PMCID: PMC4265475.

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Yin X, Mead BE, Safaee H, Langer R, Karp JM, Levy O. Engineering Stem Cell Organoids. Cell Stem Cell. 2016 Jan 7;18(1):25-38. doi: 10.1016/j.stem.2015.12.005. PMID: 26748754; PMCID: PMC4728053.

Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :

Languages

Language Proficiency :

Translation Services :

Serving Millions of physicians and biomedical scientists in Industry and academia.

Site
Services
Follow Us
Contact Us
  • support@scienceandminds.com

Copyright © 2025 Trialect Inc. All rights reserved. | v2023.06.17.02